Home › NCT04055571

Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* • All patients diagnosed and treated for pancreatic diseases, benign or malignant from 2005 to present

  * Age ≥18 years

Exclusion Criteria:

* • Patients that are not diagnosed with or treated for pancreatic diseases

  * Age \< 18 years

About the study

This study will be a retrospective chart review of patients who have been diagnosed with the benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr. Edward Cho M.D., Sc.M. at Methodist Health System Hospital in Richardson, Texas(TX). The investigators plan to conduct an analysis of patients meeting the inclusion criteria from 2005 to present. Study will also be conducted by the PI, Sub-Is, surgery fellows, office staff and clinical research coordinator who are delegated to do by the PI. Data will be obtained by looking through either investigator's patients or through a national database. Data will be analyzed primarily by the study conductors.

Sponsor: Methodist Health System · Participants: 500 · Started: Mar 5, 2019

Contact the study team

• Crystee Cooper, DHEd · Phone: 214-947-1280
• Nitasha Phatak, Ph.D. · Phone: 214-947-4459

Official record on ClinicalTrials.gov — NCT04055571

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.